These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7085917)

  • 1. Acquired dysfibrinogenaemia in liver disease.
    Francis JL; Armstrong DJ
    J Clin Pathol; 1982 Jun; 35(6):667-72. PubMed ID: 7085917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired dysfibrinogenaemia in acute and chronic liver disease.
    Lane DA; Scully MF; Thomas DP; Kakkar VV; Woolf IL; Williams R
    Br J Haematol; 1977 Feb; 35(2):301-8. PubMed ID: 870000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal fibrin polymerization in liver disease.
    Green G; Thomson JM; Dymock IW; Poller L
    Br J Haematol; 1976 Nov; 34(3):427-39. PubMed ID: 186092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfibrinogenaemia and liver cell growth.
    Barr RD; Allardyce M; Brunt PW; McPhie JL
    J Clin Pathol; 1978 Jan; 31(1):89-92. PubMed ID: 627621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen-bound sialic acid levels in the dysfibrinogenaemia of liver disease.
    Francis JL; Armstrong DJ
    Haemostasis; 1982; 11(4):215-22. PubMed ID: 6290353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfibrinogenemia associated with liver disease.
    Palascak JE; Martinez J
    J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis.
    Wilde JT; Thomas WE; Lane DA; Greaves M; Preston FE
    J Clin Pathol; 1988 Jun; 41(6):615-8. PubMed ID: 3384995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of sodium citrate in the dysfibrinogenaemia of liver disease.
    Francis JL; Watson NJ; Simmonds VJ
    Thromb Res; 1984 May; 34(3):187-97. PubMed ID: 6729777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfibrinogenemia in obstructive liver disease.
    Levy J; Pettei MJ; Weitz JI
    J Pediatr Gastroenterol Nutr; 1987; 6(6):967-70. PubMed ID: 3681583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of acquired dysfibrinogenaemia in liver disease.
    Soria J; Soria C; Ryckewaert JJ; Samama M; Thomson JM; Poller L
    Thromb Res; 1980 Jul 1-15; 19(1-2):29-41. PubMed ID: 7444857
    [No Abstract]   [Full Text] [Related]  

  • 11. Hereditary dysfibrinogenaemia (fibrinogen Jena)--report of a family study.
    Maak B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):519-22. PubMed ID: 2465965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acquired dysfibrinogenemia in a child in the course of a liver disease].
    Maak B; Meyer M; Dietze H
    Monatsschr Kinderheilkd; 1990 Aug; 138(8):446-50. PubMed ID: 2215508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired coagulation in the bleeding of chronic liver disease.
    Losowsky MS
    J R Coll Physicians Lond; 1973 Oct; 8(1):79-86. PubMed ID: 4583706
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital dysfibrinogenaemia. Two new cases (author's transl)].
    Amsellem M; Samama M; Conard J; Levyne S; Ohlgiesser C
    Nouv Presse Med; 1978 Nov; 7(41):3745-8. PubMed ID: 733523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
    Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
    J Med; 1984; 15(2):149-60. PubMed ID: 6096471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation.
    von Felten A; Straub PW; Frick PG
    N Engl J Med; 1969 Feb; 280(8):405-9. PubMed ID: 4303132
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories.
    Jennings I; Kitchen S; Menegatti M; Palla R; Walker I; Peyvandi F; Makris M
    Int J Lab Hematol; 2017 Dec; 39(6):653-662. PubMed ID: 28766854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin and acute renal failure associated with obstructive jaundice.
    Wardle EN; Wright NA
    Br Med J; 1970 Nov; 4(5733):472-4. PubMed ID: 4921235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of an abnormal plasma clot structure by a simple rigidity assay.
    Carr ME; Blatt PM; Roberts HR; Brooker JZ; Hermans J
    Thromb Haemost; 1979 Oct; 42(3):965-71. PubMed ID: 505410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.